Course Director

Mark Lebwohl, MD
Mark Lebwohl, MD

Icahn School of Medicine at Mount Sinai
New York, New York


Alice Bendix Gottlieb
Alice Bendix Gottlieb, MD, PhD

Icahn School of Medicine at Mount Sinai
New York, New York

Joanna Pomerantz
Joanna Pomerantz


Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME / MOC
Credit Amount:0.5 Credits
Release Date:2019-Oct-18
Expiration Date:2020-Oct-17
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free of Charge
Media: Enduring Material
Release and Expiration Dates: October 18, 2019 - October 17, 2020
Time to Complete: 30 minutes

Activity Description

In this activity, experts discuss the pathophysiology of psoriasis, available treatment options, and choosing the best treatment for each patient. A patient also joins the discussion to provide unique perspectives on living with psoriasis and interacting with healthcare providers.

Target Audience

This activity has been designed to meet the educational needs of dermatologists, primary care physicians, and other clinicians involved in the management of patients with moderate to severe plaque psoriasis.

Educational Objectives

Upon completion of this activity, participants should be better able to:
  • Recognize the burden of disease and unmet needs experienced by patients with moderate to severe psoriasis
  • Identify the pathophysiology of psoriasis as it relates to clinically relevant disease mechanisms and novel therapeutic targets
  • Describe current treatment options for moderate to severe psoriasis in the context of mechanism of action, efficacy, safety, and optimal clinical use
  • Employ an evidence-based, patient-centered approach to the management of moderate to severe psoriasis that considers quality of life, comorbidities, and prior treatment history

Providership, Credit, and Support

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Physician Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participation information will be shared with ABIM through the ACCME’s Program and Activity Reporting System (PARS). Blinded individual or aggregated participant data may be shared with the funder of the activity.

Faculty Disclosures

Chair and Moderator
Mark Lebwohl, MD
Professor & Chairman
Kimberly & Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Mark Lebwohl, MD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Allergan; Almirall, S.A; Arcutis; Avotres Therapeutics LLC; BirchBioMed Inc.; Boehringer Ingelheim GmbH; Bristol-Myers Squibb; Cara Therapeutics; Castle Biosciences, Inc.; Dermavant Sciences, Inc.; Inozyme Pharma; LEO Pharma Inc.; Meiji Seika Pharma Co., Ltd.; Menlo Therapeutics; Mitsubishi Tanabe Pharma America; NeuroDerm; Pfizer Inc.; Promius Pharma, LLC/Dr. Reddy’s Laboratories Ltd; Theravance Biopharma; and Verrica Pharmaceuticals.
Grant/Research Support from AbbVie Inc.; Amgen Inc.; Arcutis; AstraZeneca; Boehringer Ingelheim GmbH; Celgene Corporation; Clinuvel Pharmaceuticals Ltd.; Corrona, LLC; Eli Lilly and Company; Foundation for Research & Education of Dermatology; Incyte Corporation; Janssen Pharmaceuticals, Inc.; Kadmon Holdings, Inc.; LEO Pharma Inc.; Medimmune; Novartis Pharmaceuticals Corporation; Ortho Dermatologics; Pfizer Inc.; Sciderm; UCB Inc.; and Vidac.

Alice Bendix Gottlieb, MD, PhD
Clinical Professor and Medical Director
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Alice Bendix Gottlieb, MD, PhD, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for AbbVie Inc.; Allergan; Avotres Therapeutics LLC; Beiersdorf; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb; Celgene Corporation; Dermira, Inc.; Dr. Reddy’s Laboratories Ltd; Eli Lilly and Company; Incyte Corporation; Janssen Pharmaceuticals, Inc.; LEO Pharma Inc.; Novartis Pharmaceuticals Corporation; Sun Pharmaceutical Industries Ltd; Valeant Pharmaceuticals; UCB Inc.; and XBiotech.
Grant/Research Support from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Janssen Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; UCB Inc.; and XBiotech.

Joanna Pomerantz

Joanna Pomerantz has no financial interests/relationships or affiliations in relation to this activity.

Content Review

The following content reviewers have nothing to disclose:

Teresa Haile, RPh, MBA
Kaushal Patel, MD

Planning Committee

The planners from Medical Learning Institute, Inc., the accredited provider, and PeerView Institute for Medical Education, the joint provider, do not have any financial relationships with an ACCME-defined commercial interest related to the content of this CME/MOC activity during the past 12 months unless listed below.

Disclosure of Unlabeled Use

This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Method of Participation

Post-Test / Evaluation

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you upon completion. You will receive your certificate from If you have questions regarding the receipt of your emailed certificate, please contact via email at

About This CME/MOC Activity

PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.

Copyright © 2000-2019, PeerView

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.